{"cluster": 36, "subcluster": 50, "abstract_summ": "Objectives: To directly compare plasma levels of inflammatory cytokines, with a focus on 6 cytokines associated with cytokine storm (IL-1b, IL-1RA, IL-6, IL-8, IL-18, and TNF), between hospitalized COVID-19 patients and banked plasma samples from ARDS and sepsis patients from prior to the COVID-19 pandemic.Results showed that COVID-19 patients have higher serum level of cytokines (TNF-\u03b1, IFN-\u03b3, IL-2, IL-4, IL-6 and IL-10) and CRP than control individuals.COVIDICU patients could be clearly differentiated from COVIDstable, and demonstrated higher levels of IL-1\u03b2, IL-6 and sTNFR1 - but lower IL-10 - than CAPICU.Rationale: Elevated levels of inflammatory cytokines have been associated with poor outcomes among COVID-19 patients.Methods Forty-eight cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill, 25 severe and 14 moderate patients were measured and analyzed in combination with clinical data.", "title_summ": "Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 levelCytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsisExuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcomeA systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infectionImmune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Higher plasma levels of chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes.An inflammatory cytokine signature helps predict COVID-19 severity and deathIdentification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcomeSerum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in ChinaProfiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.Therapeutic Potential of B-1a Cells in COVID-19.Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections.", "title_abstract_phrases": "Objectives: To directly compare plasma levels of inflammatory cytokines, with a focus on 6 cytokines associated with cytokine storm (IL-1b, IL-1RA, IL-6, IL-8, IL-18, and TNF), between hospitalized COVID-19 patients and banked plasma samples from ARDS and sepsis patients from prior to the COVID-19 pandemic.Results showed that COVID-19 patients have higher serum level of cytokines (TNF-\u03b1, IFN-\u03b3, IL-2, IL-4, IL-6 and IL-10) and CRP than control individuals.COVIDICU patients could be clearly differentiated from COVIDstable, and demonstrated higher levels of IL-1\u03b2, IL-6 and sTNFR1 - but lower IL-10 - than CAPICU.Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsisRationale: Elevated levels of inflammatory cytokines have been associated with poor outcomes among COVID-19 patients.Methods Forty-eight cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill, 25 severe and 14 moderate patients were measured and analyzed in combination with clinical data."}